175 related articles for article (PubMed ID: 7559096)
1. Point mutations of ras and Gs alpha subunit genes in thyroid tumors.
Horie H; Yokogoshi Y; Tsuyuguchi M; Saito S
Jpn J Cancer Res; 1995 Aug; 86(8):737-42. PubMed ID: 7559096
[TBL] [Abstract][Full Text] [Related]
2. Point mutations of ras oncogenes are an early event in thyroid tumorigenesis.
Namba H; Rubin SA; Fagin JA
Mol Endocrinol; 1990 Oct; 4(10):1474-9. PubMed ID: 2283998
[TBL] [Abstract][Full Text] [Related]
3. Ras oncogene mutations in thyroid tumors: polymerase chain reaction-restriction-fragment-length polymorphism analysis from paraffin-embedded tissues.
Capella G; Matias-Guiu X; Ampudia X; de Leiva A; Perucho M; Prat J
Diagn Mol Pathol; 1996 Mar; 5(1):45-52. PubMed ID: 8919545
[TBL] [Abstract][Full Text] [Related]
4. N-ras mutation of thyroid tumor with special reference to the follicular type.
Oyama T; Suzuki T; Hara F; Iino Y; Ishida T; Sakamoto A; Nakajima T
Pathol Int; 1995 Jan; 45(1):45-50. PubMed ID: 7704243
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of activating ras mutations in morphologically characterized thyroid nodules.
Ezzat S; Zheng L; Kolenda J; Safarian A; Freeman JL; Asa SL
Thyroid; 1996 Oct; 6(5):409-16. PubMed ID: 8936664
[TBL] [Abstract][Full Text] [Related]
6. The thyrotropin receptor (TSH-R) is not an oncogene for thyroid tumors: structural studies of the TSH-R and the alpha-subunit of Gs in human thyroid neoplasms.
Matsuo K; Friedman E; Gejman PV; Fagin JA
J Clin Endocrinol Metab; 1993 Jun; 76(6):1446-51. PubMed ID: 8501149
[TBL] [Abstract][Full Text] [Related]
7. Rare mutations of the Gs alpha subunit gene in human endocrine tumors. Mutation detection by polymerase chain reaction-primer-introduced restriction analysis.
Yoshimoto K; Iwahana H; Fukuda A; Sano T; Itakura M
Cancer; 1993 Aug; 72(4):1386-93. PubMed ID: 8339229
[TBL] [Abstract][Full Text] [Related]
8. H-ras protooncogene mutations in human thyroid neoplasms.
Namba H; Gutman RA; Matsuo K; Alvarez A; Fagin JA
J Clin Endocrinol Metab; 1990 Jul; 71(1):223-9. PubMed ID: 2196280
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Gs alpha subunit in thyroid tumors bearing a mutated Gs alpha gene.
Gorelov VN; Dumon K; Barteneva NS; Palm D; Röher HD; Goretzki PE
J Cancer Res Clin Oncol; 1995; 121(4):219-24. PubMed ID: 7751320
[TBL] [Abstract][Full Text] [Related]
10. Variability of Ha-ras (codon 12) proto-oncogene mutations in diverse thyroid cancers.
Bouras M; Bertholon J; Dutrieux-Berger N; Parvaz P; Paulin C; Revol A
Eur J Endocrinol; 1998 Aug; 139(2):209-16. PubMed ID: 9724079
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of mutations of ras and p53 in benign and malignant thyroid tumors from children exposed to radiation after the Chernobyl nuclear accident.
Nikiforov YE; Nikiforova MN; Gnepp DR; Fagin JA
Oncogene; 1996 Aug; 13(4):687-93. PubMed ID: 8761289
[TBL] [Abstract][Full Text] [Related]
12. Selective occurrence of ras mutations in benign and malignant thyroid follicular neoplasms in Taiwan.
Liu RT; Hou CY; You HL; Huang CC; Hock-Liew ; Chou FF; Wang PW; Cheng JT
Thyroid; 2004 Aug; 14(8):616-21. PubMed ID: 15320975
[TBL] [Abstract][Full Text] [Related]
13. Specific PCR amplification for N-ras mutations in neoplastic thyroid diseases.
Kaihara M; Taniyama M; Tadatomo J; Tobe T; Tomita M; Ito K; Ban Y; Katagiri T
Endocr J; 1994 Jun; 41(3):301-8. PubMed ID: 7951583
[TBL] [Abstract][Full Text] [Related]
14. Molecular screening for somatic mutations in corticotropic adenomas of dogs with pituitary-dependent hyperadrenocorticism.
van Wijk PA; Rijnberk A; Croughs RJ; Meij BP; van Leeuwen IS; Sprang EP; Mol JA
J Endocrinol Invest; 1997 Jan; 20(1):1-7. PubMed ID: 9075064
[TBL] [Abstract][Full Text] [Related]
15. Ha-ras oncogene (codon 12) mutation in thyroid carcinogenesis: analysis of 60 benign and malignant thyroid tumors.
Bouras M; Parvaz P; Berger N; Paulin C; Revol A
Ann Biol Clin (Paris); 1995; 53(10-11):549-55. PubMed ID: 8787281
[TBL] [Abstract][Full Text] [Related]
16. [Specific amplification by PCR for N-ras mutation in thyroid follicular cartinoma].
Taniyama M; Kaihara M
Nihon Rinsho; 1994 Apr; 52(4):1075-80. PubMed ID: 8196166
[TBL] [Abstract][Full Text] [Related]
17. Activating point mutations of the gsp oncogene in human thyroid adenomas.
O'Sullivan C; Barton CM; Staddon SL; Brown CL; Lemoine NR
Mol Carcinog; 1991; 4(5):345-9. PubMed ID: 1910478
[TBL] [Abstract][Full Text] [Related]
18. Absence of activating mutations of the genes encoding the alpha-subunits of G11 and Gq in thyroid neoplasia.
Ringel MD; Saji M; Schwindinger WF; Segev D; Zeiger MA; Levine MA
J Clin Endocrinol Metab; 1998 Feb; 83(2):554-9. PubMed ID: 9467574
[TBL] [Abstract][Full Text] [Related]
19. The natural protein kinase C alpha mutant is present in human thyroid neoplasms.
Prévostel C; Alvaro V; de Boisvilliers F; Martin A; Jaffiol C; Joubert D
Oncogene; 1995 Aug; 11(4):669-74. PubMed ID: 7651730
[TBL] [Abstract][Full Text] [Related]
20. Presence of mutations in all three ras genes in human thyroid tumors.
Suarez HG; du Villard JA; Severino M; Caillou B; Schlumberger M; Tubiana M; Parmentier C; Monier R
Oncogene; 1990 Apr; 5(4):565-70. PubMed ID: 2183158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
